Appointment booking for Dr. Francisco Dexeus, MD is currently not available.Dr. Francisco Dexeus, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Francisco Dexeus, MD (he/him) is a Oncologist in Enid, OK with over 18 years of experience. What is your opinion of Dr. Francisco Dexeus, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Francisco Dexeus, MD has received over $902 which includes payments from the following companies:
$101.24 from Pfizer Inc.
$97.69 from Astellas Pharma US Inc
$86.35 from Millennium Pharmaceuticals, Inc.
$79.00 from Genentech USA, Inc.
$79.00 from Janssen Biotech, Inc.
$71.85 from Bayer HealthCare Pharmaceuticals Inc.
$59.40 from Boehringer Ingelheim Pharmaceuticals, Inc.
$53.64 from Exelixis Inc.
$44.62 from E.R. Squibb & Sons, L.L.C.
$43.72 from DFINE, Inc
$37.68 from Janssen Pharmaceuticals, Inc
$32.21 from AstraZeneca Pharmaceuticals LP
$28.53 from Teva Pharmaceuticals USA, Inc.
$17.90 from The Medicines Company
$16.83 from Amgen Inc.
$15.74 from Medtronic Sofamor Danek USA, Inc.
$13.50 from Ipsen Biopharmaceuticals, Inc
$12.90 from Medivation Inc.
$11.16 from AMAG Pharmaceuticals, Inc.
Payments received by Dr. Francisco Dexeus, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!